Search

everythinglearnresearchcommunity

for

Search:↓

New cancer drugs can cause skin side effects like rashes, dry skin, hair changes, and nail problems.

LRIG1 protein affects hair growth by regulating skin receptors, leading to hair loss when overexpressed.

Tyrosine kinase inhibitors for endocrine tumors often cause skin issues, requiring early management and treatment adjustments.

Tyrosine Kinase Inhibitors are effective against cancer but can cause skin, digestive, and blood side effects, including hair loss.

EGFR-TKIs can cause significant skin, nail, and organ side effects.

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

Gefitinib treatment led to unexpected hair growth in two lung cancer patients.

EGFR-targeting cancer drugs can cause skin rashes and other side effects.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Pemetrexed is as effective as docetaxel but has fewer side effects for treating nonsmall-cell lung cancer after EGFR-TKI therapy failure.

miR-200c-3p could help diagnose and treat alopecia areata.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Gefitinib therapy can cause unusual hair growth on the nose.

Doxycycline helps prevent skin issues from erlotinib in lung cancer patients.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Erlotinib can cause significant but temporary hair loss in lung cancer patients.

Gefitinib can cause slower, finer, brittle, and curly scalp hair.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Erlotinib can cause excessive eyelash growth.

Erlotinib can cause hair loss as a side effect.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Chemotherapy often causes skin and hair issues, but early management can help improve patient care.

EGFR inhibitors for lung cancer can cause severe skin issues.

Drug repurposing shows promise for treating many medical conditions.

ZD1839 can cause skin issues like acne and hair changes.

Lung cancer biology differs between women and men, with women responding better to certain treatments.

The compound 4c showed strong potential as an anticancer agent.

The platform effectively grows lung cancer cell spheroids for drug testing.